Related Experiment Videos

A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis

J Müller-Quernheim1, R E Schopf, P Benes

  • 1Abteilung für Pneumologie, Johannes-Gutenberg-Universität Mainz.

Klinische Wochenschrift
|October 1, 1987
PubMed

Insights

Pulmonary alveolar proteinosis (PAP) involves macrophage dysfunction. A specific protein inhibits macrophage oxidative metabolism, potentially causing infections, but bronchoalveolar lavage may help.

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare lung disease with unknown causes, often linked to macrophage dysfunction.
  • Investigating alveolar macrophage function is crucial for understanding PAP pathogenesis and associated infections.

Observation:

  • Alveolar macrophages in PAP patients exhibit normal phagocytosis and oxidative burst in response to certain stimulants.
  • However, these macrophages show no stimulated oxidative metabolism when exposed to phorbolmyristate acetate or aggregated immunoglobulin.

Findings:

  • A 40-kD protein isolated from lavage fluid was identified as the mediator of this macrophage-inhibiting effect.
  • This inhibition of macrophage oxidative metabolism is a key finding in the studied case of PAP.

Implications:

  • The observed macrophage dysfunction may explain the high incidence of opportunistic infections in PAP patients.
  • Therapeutic bronchoalveolar lavage could be a viable early-stage treatment to remove the inhibitory protein and reduce infection risk.

Related Concept Videos